Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Primary results of clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): reactions frequency in multibacillary patients.

Penna ML, Buhrer-Sékula S, Pontes MA, Cruz R, Gonçalves Hde S, Penna GO.

Lepr Rev. 2012 Sep;83(3):308-19.

PMID:
23356032
2.

Results from the clinical trial of uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): decrease in bacteriological index.

Penna ML, Bűhrer-Sékula S, Pontes MA, Cruz R, Gonçalves Hde S, Penna GO.

Lepr Rev. 2014 Dec;85(4):262-6.

PMID:
25675650
3.

Relapses in multibacillary leprosy patients: a retrospective cohort of 11 years in Colombia.

Guerrero-Guerrero MI, Muvdi-Arenas S, León-Franco CI.

Lepr Rev. 2012 Sep;83(3):247-60.

PMID:
23356026
4.

OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil.

Cunha Mda G, Virmond M, Schettini AP, Cruz RC, Ura S, Ghuidella C, Viana Fdos R, Avelleira JC, Campos AA, Filho B.

Lepr Rev. 2012 Sep;83(3):261-8.

PMID:
23356027
6.

Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.

Penna GO, Bührer-Sékula S, Kerr LRS, Stefani MMA, Rodrigues LC, de Araújo MG, Ramos AMC, de Andrade ARC, Costa MB, Rosa PS, Gonçalves HS, Cruz R, Barreto ML, Pontes MAA, Penna MLF.

PLoS Negl Trop Dis. 2017 Jul 13;11(7):e0005725. doi: 10.1371/journal.pntd.0005725. eCollection 2017 Jul.

7.

Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.

Hungria EM, Oliveira RM, Penna GO, Aderaldo LC, Pontes MA, Cruz R, Gonçalves HS, Penna ML, Kerr LR, Stefani MM, Bührer-Sékula S.

Infect Dis Poverty. 2016 Dec 6;5(1):110.

10.

Bacteriological results and leprosy reactions among MB leprosy patients treated with uniform multidrug therapy in China.

Shen J, Bathyala N, Kroeger A, Arana B, Pannikar V, Mou H, Bao X, Yang R, Manickam P, Li W, Zhou M, Want J.

Lepr Rev. 2012 Jun;83(2):164-71.

PMID:
22997692
11.

Presence of M. leprae in tissues in slit skin smear negative multibacillary (MB) patients after WHO-MBR.

Sharma A, Sharma VK, Rajwanshi A, Das A, Kaur I, Kumar B.

Lepr Rev. 1999 Sep;70(3):281-6.

PMID:
10603717
12.

Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin.

Katoch K, Katoch VM, Natarajan M, Gupta UD, Sharma VD, Singh HB.

Indian J Lepr. 2008 Oct-Dec;80(4):331-44.

PMID:
20329382
13.

A clinical trial for uniform multidrug therapy for leprosy patients in Brazil: rationale and design.

Penna GO, Pontes MA, Cruz R, Gonçalves Hde S, Penna ML, Bührer-Sékula S.

Mem Inst Oswaldo Cruz. 2012 Dec;107 Suppl 1:22-7.

15.

Leprosy in transplant recipients: report of a case after liver transplantation and review of the literature.

Trindade MA, Palermo ML, Pagliari C, Valente N, Naafs B, Massarollo PC, D'Albuquerque LA, Benard G.

Transpl Infect Dis. 2011 Feb;13(1):63-9. doi: 10.1111/j.1399-3062.2010.00549.x. Review. Erratum in: Transpl Infect Dis. 2011 Feb;13(1):99.

PMID:
20678090
16.

Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines.

Maghanoy A, Mallari I, Balagon M, Saunderson P.

Lepr Rev. 2011 Mar;82(1):65-9.

PMID:
21644473
17.

Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.

Kaur I, Dogra S, Kumar B, Radotra BD.

Int J Lepr Other Mycobact Dis. 2002 Sep;70(3):174-81.

PMID:
12483965
18.

Six years' follow-up of multibacillary leprosy patients treated with uniform multi-drug therapy in China.

Shen J, Yan L, Yu M, Li J, Yu X, Zhang G.

Int J Dermatol. 2015 Mar;54(3):315-8. doi: 10.1111/ijd.12573. Epub 2014 Sep 30.

PMID:
25265933
19.

Reactional states and neuritis in multibacillary leprosy patients following MDT with/without immunotherapy with Mycobacterium w antileprosy vaccine.

Sharma P, Kar HK, Misra RS, Mukherjee A, Kaur H, Mukherjee R, Rani R.

Lepr Rev. 2000 Jun;71(2):193-205.

PMID:
10920614
20.

Relapses in multibacillary leprosy patients after multidrug therapy.

Poojabylaiah M, Marne RB, Varikkodan R, Bala N, Dandakeri S, Martis J.

Lepr Rev. 2008 Sep;79(3):320-4.

PMID:
19009982

Supplemental Content

Support Center